Protease inhibitors in HIV infection

In contrast, a detailed report on a large series of patients has provided impressive evidence that the use of protease inhibitors in HIV-infected patients with hereditary bleeding disorders can lead to an increased bleeding tendency (41). This effect, which is most likely to occur when ritonavir is used, is also unexplained. 

Use of fosamprenavir, a sulfa-containing protease inhibitor, in HIV-infected patients with glucose-6-phosphate dehydrogenase deficiency. 

---

See also in sourсe #XX -- [ , , , , , , , , , ]

See also in sourсe #XX -- [ ]

---